EcoDrugPlus

Granzyme B-Like

Ensembl ID : ENSLOCG00000005263
Gene Symbol: LOC102686644
2 Cross references
884 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSLOCG00000009533
Gene Symbol: GHRHR
4 Cross references
191 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSLOCG00000007476
Gene Symbol: GHSR
3 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSLOCG00000008256
Gene Symbol: GUCY1A1
3 Cross references
200 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSLOCG00000006889
Gene Symbol: GUCY1A2
2 Cross references
128 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class A Member 1

Ensembl ID : ENSLOCG00000011504
Gene Symbol: HSP90AA1
3 Cross references
330 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class B Member 1

Ensembl ID : ENSLOCG00000016396
Gene Symbol: HSP90AB1
3 Cross references
82 Possible Orthologues:

Heat Shock Protein Hsp 90-Alpha

Ensembl ID : ENSLOCG00000000071
Gene Symbol: LOC102693534
3 Cross references
346 Possible Orthologues:

High Mobility Group Box 1

Ensembl ID : ENSLOCG00000000187
Gene Symbol: HMGB1
3 Cross references
582 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSLOCG00000013921
Gene Symbol: HRH1
2 Cross references
186 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSLOCG00000009751
Gene Symbol: HRH2A
1 Cross references
249 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSLOCG00000002539
Gene Symbol: HDAC1
3 Cross references
309 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).